BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tan AH, Mahadeva S, Thalha AM, Gibson PR, Kiew CK, Yeat CM, Ng SW, Ang SP, Chow SK, Tan CT. Small intestinal bacterial overgrowth in Parkinson’s disease. Parkinsonism Relat Disord. 2014;20:535-540. [PMID: 24637123 DOI: 10.1016/j.parkreldis.2014.02.019] [Cited by in Crossref: 136] [Cited by in F6Publishing: 123] [Article Influence: 17.0] [Reference Citation Analysis]
Number Citing Articles
1 Cui C, Han Y, Li H, Yu H, Zhang B, Li G. Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson's disease. Front Cell Infect Microbiol 2022;12:887407. [PMID: 36034698 DOI: 10.3389/fcimb.2022.887407] [Reference Citation Analysis]
2 Bhidayasiri R, Phuenpathom W, Tan AH, Leta V, Phumphid S, Chaudhuri KR, Pal PK. Management of dysphagia and gastroparesis in Parkinson’s disease in real-world clinical practice – Balancing pharmacological and non-pharmacological approaches. Front Aging Neurosci 2022;14:979826. [DOI: 10.3389/fnagi.2022.979826] [Reference Citation Analysis]
3 Chen SJ, Lin CH. Gut microenvironmental changes as a potential trigger in Parkinson's disease through the gut-brain axis. J Biomed Sci 2022;29:54. [PMID: 35897024 DOI: 10.1186/s12929-022-00839-6] [Reference Citation Analysis]
4 Ahmed JF, Padam P, Ruban A. Aetiology, diagnosis and management of small intestinal bacterial overgrowth. Frontline Gastroenterol. [DOI: 10.1136/flgastro-2022-102163] [Reference Citation Analysis]
5 Castillo-Álvarez F, Marzo-Sola ME. Role of the gut microbiota in the development of various neurological diseases. Neurologia (Engl Ed) 2022;37:492-8. [PMID: 35779869 DOI: 10.1016/j.nrleng.2019.03.026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Tan AH, Lim SY, Lang AE. The microbiome-gut-brain axis in Parkinson disease - from basic research to the clinic. Nat Rev Neurol 2022. [PMID: 35750883 DOI: 10.1038/s41582-022-00681-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Beckers M, Bloem BR, Verbeek MM. Mechanisms of peripheral levodopa resistance in Parkinson's disease. NPJ Parkinsons Dis 2022;8:56. [PMID: 35546556 DOI: 10.1038/s41531-022-00321-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Olubodun-Obadun TG, Ishola IO, Adeyemi OO. Impact of environmental toxicants exposure on gut-brain axis in Parkinson disease. Drug Metab Pers Ther 2022. [PMID: 35377569 DOI: 10.1515/dmpt-2021-0144] [Reference Citation Analysis]
9 Guo T, Chen L. Gut microbiota and inflammation in Parkinson’s disease: Pathogenetic and therapeutic insights. Eur J Inflamm 2022;20:1721727X2210837. [DOI: 10.1177/1721727x221083763] [Reference Citation Analysis]
10 Zhang H, Chen Y, Wang Z, Xie G, Liu M, Yuan B, Chai H, Wang W, Cheng P. Implications of Gut Microbiota in Neurodegenerative Diseases. Front Immunol 2022;13:785644. [DOI: 10.3389/fimmu.2022.785644] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 van Kessel SP, Bullock A, van Dijk G, El Aidy S. Parkinson's Disease Medication Alters Small Intestinal Motility and Microbiota Composition in Healthy Rats. mSystems 2022;:e0119121. [PMID: 35076270 DOI: 10.1128/msystems.01191-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Safarpour D, Sharzehi K, Pfeiffer RF. Gastrointestinal Dysfunction in Parkinson’s Disease. Drugs. [DOI: 10.1007/s40265-021-01664-1] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Alfonsetti M, Castelli V, d'Angelo M. Are We What We Eat? Impact of Diet on the Gut-Brain Axis in Parkinson's Disease. Nutrients 2022;14:380. [PMID: 35057561 DOI: 10.3390/nu14020380] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
14 Tkach S, Dorofeyev A, Kuzenko I, Boyko N, Falalyeyeva T, Boccuto L, Scarpellini E, Kobyliak N, Abenavoli L. Current Status and Future Therapeutic Options for Fecal Microbiota Transplantation. Medicina (Kaunas) 2022;58:84. [PMID: 35056392 DOI: 10.3390/medicina58010084] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Sorboni SG, Moghaddam HS, Jafarzadeh-Esfehani R, Soleimanpour S. A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders. Clin Microbiol Rev 2022;:e0033820. [PMID: 34985325 DOI: 10.1128/CMR.00338-20] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
16 Anis E, Xie A, Brundin L, Brundin P. Digesting recent findings: gut alpha-synuclein, microbiome changes in Parkinson's disease. Trends Endocrinol Metab 2021:S1043-2760(21)00268-X. [PMID: 34949514 DOI: 10.1016/j.tem.2021.11.005] [Reference Citation Analysis]
17 Verugina NI, Levin OS, Lyashenko EA. [The role of the gut microbiota in Parkinson's disease]. Zh Nevrol Psikhiatr Im S S Korsakova 2021;121:86-91. [PMID: 34870920 DOI: 10.17116/jnevro202112110286] [Reference Citation Analysis]
18 Yuan X, Tian Y, Liu C, Zhang Z. Environmental factors in Parkinson's disease: New insights into the molecular mechanisms. Toxicol Lett 2021;356:1-10. [PMID: 34864130 DOI: 10.1016/j.toxlet.2021.12.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Khedr EM, Ali AM, Deaf E, Hassan HM, Alaa A, Gamea A. Gut microbiota in Parkinson’s disease patients: hospital-based study. Egypt J Neurol Psychiatry Neurosurg 2021;57. [DOI: 10.1186/s41983-021-00407-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Kaur S, Thukral SK, Kaur P, Samota MK. Perturbations associated with hungry gut microbiome and postbiotic perspectives to strengthen the microbiome health. Future Foods 2021;4:100043. [DOI: 10.1016/j.fufo.2021.100043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Glinert A, Turjeman S, Elliott E, Koren O. Microbes, metabolites and (synaptic) malleability, oh my! The effect of the microbiome on synaptic plasticity. Biol Rev Camb Philos Soc 2021. [PMID: 34734461 DOI: 10.1111/brv.12812] [Reference Citation Analysis]
22 Dănău A, Dumitrescu L, Lefter A, Tulbă D, Popescu BO. Small Intestinal Bacterial Overgrowth as Potential Therapeutic Target in Parkinson's Disease. Int J Mol Sci 2021;22:11663. [PMID: 34769091 DOI: 10.3390/ijms222111663] [Reference Citation Analysis]
23 Sharabi Y, Vatine GD, Ashkenazi A. Parkinson's disease outside the brain: targeting the autonomic nervous system. Lancet Neurol 2021;20:868-76. [PMID: 34536407 DOI: 10.1016/S1474-4422(21)00219-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Bindas AJ, Kulkarni S, Koppes RA, Koppes AN. Parkinson's disease and the gut: Models of an emerging relationship. Acta Biomater 2021;132:325-44. [PMID: 33857691 DOI: 10.1016/j.actbio.2021.03.071] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
25 Kempster PA, Perju-Dumbrava L. The Thermodynamic Consequences of Parkinson's Disease. Front Neurol 2021;12:685314. [PMID: 34512508 DOI: 10.3389/fneur.2021.685314] [Reference Citation Analysis]
26 Fonseca Cabral G, Schaan AP, Cavalcante GC, Sena-Dos-Santos C, de Souza TP, Souza Port's NM, Dos Santos Pinheiro JA, Ribeiro-Dos-Santos Â, Vidal AF. Nuclear and Mitochondrial Genome, Epigenome and Gut Microbiome: Emerging Molecular Biomarkers for Parkinson's Disease. Int J Mol Sci 2021;22:9839. [PMID: 34576000 DOI: 10.3390/ijms22189839] [Reference Citation Analysis]
27 Fu J, Li Z, Wang F, Yu K. Prevalence of malnutrition/malnutrition risk and nutrition-related risk factors among patients with Parkinson's disease: systematic review and meta-analysis. Nutr Neurosci 2021;:1-11. [PMID: 34238139 DOI: 10.1080/1028415X.2021.1948655] [Reference Citation Analysis]
28 Yemula N, Dietrich C, Dostal V, Hornberger M. Parkinson's Disease and the Gut: Symptoms, Nutrition, and Microbiota. J Parkinsons Dis 2021. [PMID: 34250955 DOI: 10.3233/JPD-212707] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Gallop A, Weagley J, Paracha SU, Grossberg G. The Role of The Gut Microbiome in Parkinson's Disease. J Geriatr Psychiatry Neurol 2021;34:253-62. [PMID: 34219519 DOI: 10.1177/08919887211018268] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
30 Bai F, Li X. Association of Helicobacter pylori treatment with Parkinsonism and related disorders: A systematic review and meta-analysis. Life Sci 2021;281:119767. [PMID: 34216625 DOI: 10.1016/j.lfs.2021.119767] [Reference Citation Analysis]
31 Menozzi E, Macnaughtan J, Schapira AHV. The gut-brain axis and Parkinson disease: clinical and pathogenetic relevance. Ann Med 2021;53:611-25. [PMID: 33860738 DOI: 10.1080/07853890.2021.1890330] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
32 Li X, Feng X, Jiang Z, Jiang Z. Association of small intestinal bacterial overgrowth with Parkinson's disease: a systematic review and meta-analysis. Gut Pathog 2021;13:25. [PMID: 33863370 DOI: 10.1186/s13099-021-00420-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Steinbach MJ, Campbell RW, DeVore BB, Harrison DW. Laterality in Parkinson's disease: a neuropsychological review. Appl Neuropsychol Adult 2021;:1-15. [PMID: 33844619 DOI: 10.1080/23279095.2021.1907392] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Liu X, Liu S, Tang Y, Pu Z, Xiao H, Gao J, Yin Q, Jia Y, Bai Q. Intragastric Administration of Casein Leads to Nigrostriatal Disease Progressed Accompanied with Persistent Nigrostriatal-Intestinal Inflammation Activited and Intestinal Microbiota-Metabolic Disorders Induced in MPTP Mouse Model of Parkinson's Disease. Neurochem Res 2021;46:1514-39. [PMID: 33719004 DOI: 10.1007/s11064-021-03293-2] [Reference Citation Analysis]
35 Dogra N, Mani RJ, Katare DP. The Gut-Brain Axis: Two Ways Signaling in Parkinson's Disease. Cell Mol Neurobiol 2021. [PMID: 33649989 DOI: 10.1007/s10571-021-01066-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
36 Nyholm D, Hellström PM. Effects of Helicobacter pylori on Levodopa Pharmacokinetics. J Parkinsons Dis 2021;11:61-9. [PMID: 33164946 DOI: 10.3233/JPD-202298] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
37 Skjærbæk C, Knudsen K, Horsager J, Borghammer P. Gastrointestinal Dysfunction in Parkinson's Disease. J Clin Med 2021;10:493. [PMID: 33572547 DOI: 10.3390/jcm10030493] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
38 Zhang Z, Chen SD. Autonomic Dysfunctions in Parkinson's Disease: Prevalence, Clinical Characteristics, Potential Diagnostic Markers, and Treatment. Parkinsons Dis 2020;2020:8740732. [PMID: 33425317 DOI: 10.1155/2020/8740732] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Tan AH, Chong CW, Lim SY, Yap IKS, Teh CSJ, Loke MF, Song SL, Tan JY, Ang BH, Tan YQ, Kho MT, Bowman J, Mahadeva S, Yong HS, Lang AE. Gut Microbial Ecosystem in Parkinson Disease: New Clinicobiological Insights from Multi-Omics. Ann Neurol 2021;89:546-59. [PMID: 33274480 DOI: 10.1002/ana.25982] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
40 Rani L, Mondal AC. Unravelling the role of gut microbiota in Parkinson's disease progression: Pathogenic and therapeutic implications. Neurosci Res 2021;168:100-12. [PMID: 33417973 DOI: 10.1016/j.neures.2021.01.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
41 Rajput C, Sarkar A, Sachan N, Rawat N, Singh MP. Is Gut Dysbiosis an Epicenter of Parkinson's Disease? Neurochem Res 2021;46:425-38. [PMID: 33400024 DOI: 10.1007/s11064-020-03187-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Kang Y, Kang X, Zhang H, Liu Q, Yang H, Fan W. Gut Microbiota and Parkinson's Disease: Implications for Faecal Microbiota Transplantation Therapy. ASN Neuro 2021;13:17590914211016217. [PMID: 34053243 DOI: 10.1177/17590914211016217] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
43 Kaur G, Behl T, Bungau S, Kumar A, Uddin MS, Mehta V, Zengin G, Mathew B, Shah MA, Arora S. Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinson's Disease. Curr Neuropharmacol 2021;19:233-47. [PMID: 32504503 DOI: 10.2174/1570159X18666200606233050] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
44 Chung KA, Pfeiffer RF. Gastrointestinal dysfunction in the synucleinopathies. Clin Auton Res 2021;31:77-99. [PMID: 33247399 DOI: 10.1007/s10286-020-00745-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
45 Tan AH, Hor JW, Chong CW, Lim SY. Probiotics for Parkinson's disease: Current evidence and future directions. JGH Open 2021;5:414-9. [PMID: 33860090 DOI: 10.1002/jgh3.12450] [Reference Citation Analysis]
46 El Kurdi B, Babar S, El Iskandarani M, Bataineh A, Lerch MM, Young M, Singh VP. Factors That Affect Prevalence of Small Intestinal Bacterial Overgrowth in Chronic Pancreatitis: A Systematic Review, Meta-Analysis, and Meta-Regression. Clin Transl Gastroenterol 2019;10:e00072. [PMID: 31517648 DOI: 10.14309/ctg.0000000000000072] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
47 Leggio L, Paternò G, Vivarelli S, L'Episcopo F, Tirolo C, Raciti G, Pappalardo F, Giachino C, Caniglia S, Serapide MF, Marchetti B, Iraci N. Extracellular Vesicles as Nanotherapeutics for Parkinson's Disease. Biomolecules 2020;10:E1327. [PMID: 32948090 DOI: 10.3390/biom10091327] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
48 Yakhine-Diop SMS, Morales-García JA, Niso-Santano M, González-Polo RA, Uribe-Carretero E, Martinez-Chacon G, Durand S, Maiuri MC, Aiastui A, Zulaica M, Ruíz-Martínez J, López de Munain A, Pérez-Tur J, Pérez-Castillo A, Kroemer G, Bravo-San Pedro JM, Fuentes JM. Metabolic alterations in plasma from patients with familial and idiopathic Parkinson's disease. Aging (Albany NY) 2020;12:16690-708. [PMID: 32903216 DOI: 10.18632/aging.103992] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
49 Schaeffer E, Kluge A, Böttner M, Zunke F, Cossais F, Berg D, Arnold P. Alpha Synuclein Connects the Gut-Brain Axis in Parkinson's Disease Patients - A View on Clinical Aspects, Cellular Pathology and Analytical Methodology. Front Cell Dev Biol 2020;8:573696. [PMID: 33015066 DOI: 10.3389/fcell.2020.573696] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
50 Tan AH, Lim S, Mahadeva S, Loke MF, Tan JY, Ang BH, Chin KP, Mohammad Adnan AF, Ong SMC, Ibrahim AI, Zulkifli N, Lee JK, Lim WT, Teo YT, Kok YL, Ng TY, Tan AGS, Zulkifle IM, Ng CK, Ee SS, Arafin S, Mohamad Shukori K, Vadivelu JS, Marras C, Fox SH, Lang AE. Helicobacter pylori Eradication in Parkinson's Disease: A Randomized Placebo‐Controlled Trial. Mov Disord 2020;35:2250-60. [DOI: 10.1002/mds.28248] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
51 Roy M, Péré M, Damier P, Bruley des Varannes S, Derkinderen P, Rouaud T. STW5 (Iberogast®) for constipation in Parkinson's disease. Rev Neurol (Paris) 2021;177:296-301. [PMID: 32829914 DOI: 10.1016/j.neurol.2020.06.005] [Reference Citation Analysis]
52 Pfeiffer RF. Autonomic Dysfunction in Parkinson's Disease. Neurotherapeutics 2020;17:1464-79. [PMID: 32789741 DOI: 10.1007/s13311-020-00897-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
53 Ceppa FA, Izzo L, Sardelli L, Raimondi I, Tunesi M, Albani D, Giordano C. Human Gut-Microbiota Interaction in Neurodegenerative Disorders and Current Engineered Tools for Its Modeling. Front Cell Infect Microbiol 2020;10:297. [PMID: 32733812 DOI: 10.3389/fcimb.2020.00297] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
54 Tucker RM, Ryan S, Hayee BH, Bjarnason I, Augustin AD, Umamahesan C, Taylor D, Weller C, Dobbs SM, Dobbs RJ, Charlett A. Distinctive Pathophysiology Underlying Constipation in Parkinson's Disease: Implications for Cognitive Inefficiency. J Clin Med 2020;9:E1916. [PMID: 32575365 DOI: 10.3390/jcm9061916] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
55 Tilocca B, Pieroni L, Soggiu A, Britti D, Bonizzi L, Roncada P, Greco V. Gut-Brain Axis and Neurodegeneration: State-of-the-Art of Meta-Omics Sciences for Microbiota Characterization. Int J Mol Sci 2020;21:E4045. [PMID: 32516966 DOI: 10.3390/ijms21114045] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
56 Losurdo G, Salvatore D'Abramo F, Indellicati G, Lillo C, Ierardi E, Di Leo A. The Influence of Small Intestinal Bacterial Overgrowth in Digestive and Extra-Intestinal Disorders. Int J Mol Sci 2020;21:E3531. [PMID: 32429454 DOI: 10.3390/ijms21103531] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
57 Christine CW, Auinger P, Saleh N, Tian M, Bottiglieri T, Arning E, Tran NK, Ueland PM, Green R; Parkinson Study Group-DATATOP Investigators. Relationship of Cerebrospinal Fluid Vitamin B12 Status Markers With Parkinson's Disease Progression. Mov Disord 2020;35:1466-71. [PMID: 32407590 DOI: 10.1002/mds.28073] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
58 Foo ASC, Soong TW, Yeo TT, Lim KL. Mitochondrial Dysfunction and Parkinson's Disease-Near-Infrared Photobiomodulation as a Potential Therapeutic Strategy. Front Aging Neurosci 2020;12:89. [PMID: 32308618 DOI: 10.3389/fnagi.2020.00089] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
59 Baizabal-carvallo JF, Alonso-juarez M. The Link between Gut Dysbiosis and Neuroinflammation in Parkinson’s Disease. Neuroscience 2020;432:160-73. [DOI: 10.1016/j.neuroscience.2020.02.030] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 12.0] [Reference Citation Analysis]
60 Vendrik KEW, Ooijevaar RE, de Jong PRC, Laman JD, van Oosten BW, van Hilten JJ, Ducarmon QR, Keller JJ, Kuijper EJ, Contarino MF. Fecal Microbiota Transplantation in Neurological Disorders. Front Cell Infect Microbiol 2020;10:98. [PMID: 32266160 DOI: 10.3389/fcimb.2020.00098] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 23.5] [Reference Citation Analysis]
61 Elfil M, Kamel S, Kandil M, Koo BB, Schaefer SM. Implications of the Gut Microbiome in Parkinson's Disease. Mov Disord 2020;35:921-33. [DOI: 10.1002/mds.28004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 13.5] [Reference Citation Analysis]
62 Fu P, Gao M, Yung KKL. Association of Intestinal Disorders with Parkinson's Disease and Alzheimer's Disease: A Systematic Review and Meta-Analysis. ACS Chem Neurosci 2020;11:395-405. [PMID: 31876406 DOI: 10.1021/acschemneuro.9b00607] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 17.5] [Reference Citation Analysis]
63 Ilie OD, Ciobica A, McKenna J, Doroftei B, Mavroudis I. Minireview on the Relations between Gut Microflora and Parkinson's Disease: Further Biochemical (Oxidative Stress), Inflammatory, and Neurological Particularities. Oxid Med Cell Longev 2020;2020:4518023. [PMID: 32089768 DOI: 10.1155/2020/4518023] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
64 Nuzum ND, Loughman A, Szymlek-Gay EA, Hendy A, Teo WP, Macpherson H. Gut microbiota differences between healthy older adults and individuals with Parkinson's disease: A systematic review. Neurosci Biobehav Rev 2020;112:227-41. [PMID: 32032654 DOI: 10.1016/j.neubiorev.2020.02.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
65 Sampson T. The impact of indigenous microbes on Parkinson's disease. Neurobiology of Disease 2020;135:104426. [DOI: 10.1016/j.nbd.2019.03.014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
66 Madore C, Yin Z, Leibowitz J, Butovsky O. Microglia, Lifestyle Stress, and Neurodegeneration. Immunity 2020;52:222-40. [PMID: 31924476 DOI: 10.1016/j.immuni.2019.12.003] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 26.5] [Reference Citation Analysis]
67 Choi J, Ju I, Huh E, Noh D, Gu P, Oh M. Effects of indoxyl sulfate on dopaminergic neurons and motor functions. J Pharm Negative Results 2020;11:30. [DOI: 10.4103/jpnr.jpnr_23_19] [Reference Citation Analysis]
68 Chen Z, Li G, Liu J. Autonomic dysfunction in Parkinson's disease: Implications for pathophysiology, diagnosis, and treatment. Neurobiol Dis 2020;134:104700. [PMID: 31809788 DOI: 10.1016/j.nbd.2019.104700] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
69 Chaiwiang N, Poyomtip T. Microbial dysbiosis and microbiota-gut-retina axis: The lesson from brain neurodegenerative diseases to primary open-angle glaucoma pathogenesis of autoimmunity. Acta Microbiol Immunol Hung 2019;66:541-58. [PMID: 31786943 DOI: 10.1556/030.66.2019.038] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
70 Yang D, Zhao D, Ali Shah SZ, Wu W, Lai M, Zhang X, Li J, Guan Z, Zhao H, Li W, Gao H, Zhou X, Yang L. The Role of the Gut Microbiota in the Pathogenesis of Parkinson's Disease. Front Neurol 2019;10:1155. [PMID: 31781020 DOI: 10.3389/fneur.2019.01155] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 12.3] [Reference Citation Analysis]
71 Kim Y, Lee C, Kim S, Jang J, Lee S, Lee S. Risk of Parkinson’s disease after colectomy: longitudinal follow-up study using a national sample cohort. J Neurol 2020;267:513-21. [DOI: 10.1007/s00415-019-09617-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
72 Hasuike Y, Endo T, Koroyasu M, Matsui M, Mori C, Yamadera M, Fujimura H, Sakoda S. Bile acid abnormality induced by intestinal dysbiosis might explain lipid metabolism in Parkinson's disease. Med Hypotheses 2020;134:109436. [PMID: 31678900 DOI: 10.1016/j.mehy.2019.109436] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
73 Maitra U, Scaglione MN, Chtarbanova S, O'Donnell JM. Innate immune responses to paraquat exposure in a Drosophila model of Parkinson's disease. Sci Rep 2019;9:12714. [PMID: 31481676 DOI: 10.1038/s41598-019-48977-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
74 Kalampokini S, Becker A, Fassbender K, Lyros E, Unger MM. Nonpharmacological Modulation of Chronic Inflammation in Parkinson's Disease: Role of Diet Interventions. Parkinsons Dis 2019;2019:7535472. [PMID: 31534664 DOI: 10.1155/2019/7535472] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
75 Gazerani P. Probiotics for Parkinson's Disease. Int J Mol Sci 2019;20:E4121. [PMID: 31450864 DOI: 10.3390/ijms20174121] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
76 Castillo-Álvarez F, Marzo-Sola ME. Role of the gut microbiota in the development of various neurological diseases. Neurologia (Engl Ed) 2019:S0213-4853(19)30082-9. [PMID: 31340904 DOI: 10.1016/j.nrl.2019.03.017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
77 Ambrosini YM, Borcherding D, Kanthasamy A, Kim HJ, Willette AA, Jergens A, Allenspach K, Mochel JP. The Gut-Brain Axis in Neurodegenerative Diseases and Relevance of the Canine Model: A Review. Front Aging Neurosci 2019;11:130. [PMID: 31275138 DOI: 10.3389/fnagi.2019.00130] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 10.0] [Reference Citation Analysis]
78 Chiang HL, Lin CH. Altered Gut Microbiome and Intestinal Pathology in Parkinson's Disease. J Mov Disord 2019;12:67-83. [PMID: 31158941 DOI: 10.14802/jmd.18067] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
79 Dietiker C, Kim S, Zhang Y, Christine CW. Characterization of Vitamin B12 Supplementation and Correlation with Clinical Outcomes in a Large Longitudinal Study of Early Parkinson's Disease. J Mov Disord 2019;12:91-6. [PMID: 31158942 DOI: 10.14802/jmd.18049] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
80 Perez-Pardo P, Dodiya HB, Engen PA, Forsyth CB, Huschens AM, Shaikh M, Voigt RM, Naqib A, Green SJ, Kordower JH, Shannon KM, Garssen J, Kraneveld AD, Keshavarzian A. Role of TLR4 in the gut-brain axis in Parkinson's disease: a translational study from men to mice. Gut 2019;68:829-43. [PMID: 30554160 DOI: 10.1136/gutjnl-2018-316844] [Cited by in Crossref: 155] [Cited by in F6Publishing: 128] [Article Influence: 51.7] [Reference Citation Analysis]
81 Lubomski M, Tan AH, Lim SY, Holmes AJ, Davis RL, Sue CM. Parkinson's disease and the gastrointestinal microbiome. J Neurol 2020;267:2507-23. [PMID: 31041582 DOI: 10.1007/s00415-019-09320-1] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 14.3] [Reference Citation Analysis]
82 Roy Sarkar S, Banerjee S. Gut microbiota in neurodegenerative disorders. Journal of Neuroimmunology 2019;328:98-104. [DOI: 10.1016/j.jneuroim.2019.01.004] [Cited by in Crossref: 90] [Cited by in F6Publishing: 80] [Article Influence: 30.0] [Reference Citation Analysis]
83 van Kessel SP, Frye AK, El-Gendy AO, Castejon M, Keshavarzian A, van Dijk G, El Aidy S. Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson's disease. Nat Commun 2019;10:310. [PMID: 30659181 DOI: 10.1038/s41467-019-08294-y] [Cited by in Crossref: 127] [Cited by in F6Publishing: 116] [Article Influence: 42.3] [Reference Citation Analysis]
84 Quigley EMM. The Spectrum of Small Intestinal Bacterial Overgrowth (SIBO). Curr Gastroenterol Rep. 2019;21:3. [PMID: 30645678 DOI: 10.1007/s11894-019-0671-z] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 13.0] [Reference Citation Analysis]
85 de Waal GM, Engelbrecht L, Davis T, de Villiers WJS, Kell DB, Pretorius E. Correlative Light-Electron Microscopy detects lipopolysaccharide and its association with fibrin fibres in Parkinson's Disease, Alzheimer's Disease and Type 2 Diabetes Mellitus. Sci Rep 2018;8:16798. [PMID: 30429533 DOI: 10.1038/s41598-018-35009-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
86 Kujawska M, Jodynis-Liebert J. What is the Evidence That Parkinson's Disease is a Prion Disorder, Which Originates in the Gut? Int J Mol Sci 2018;19:E3573. [PMID: 30424585 DOI: 10.3390/ijms19113573] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
87 Abdel-Haq R, Schlachetzki JCM, Glass CK, Mazmanian SK. Microbiome-microglia connections via the gut-brain axis. J Exp Med 2019;216:41-59. [PMID: 30385457 DOI: 10.1084/jem.20180794] [Cited by in Crossref: 88] [Cited by in F6Publishing: 78] [Article Influence: 22.0] [Reference Citation Analysis]
88 Pfeiffer RF. Gastrointestinal Dysfunction in Parkinson's Disease. Curr Treat Options Neurol. 2018;20:54. [PMID: 30361783 DOI: 10.1007/s11940-018-0539-9] [Cited by in Crossref: 45] [Cited by in F6Publishing: 35] [Article Influence: 11.3] [Reference Citation Analysis]
89 Perez-pardo P, Dodiya H, Engen P, Naqib A, Forsyth C, Green S, Garssen J, Keshavarzian A, Kraneveld A. Gut bacterial composition in a mouse model of Parkinson’s disease. Beneficial Microbes 2018;9:799-814. [DOI: 10.3920/bm2017.0202] [Cited by in Crossref: 36] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
90 Sun MF, Shen YQ. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease. Ageing Res Rev 2018;45:53-61. [PMID: 29705121 DOI: 10.1016/j.arr.2018.04.004] [Cited by in Crossref: 136] [Cited by in F6Publishing: 113] [Article Influence: 34.0] [Reference Citation Analysis]
91 Lin A, Zheng W, He Y, Tang W, Wei X, He R, Huang W, Su Y, Huang Y, Zhou H, Xie H. Gut microbiota in patients with Parkinson's disease in southern China. Parkinsonism & Related Disorders 2018;53:82-8. [DOI: 10.1016/j.parkreldis.2018.05.007] [Cited by in Crossref: 90] [Cited by in F6Publishing: 81] [Article Influence: 22.5] [Reference Citation Analysis]
92 Knudsen K, Szwebs M, Hansen AK, Borghammer P. Gastric emptying in Parkinson's disease - A mini-review. Parkinsonism Relat Disord 2018;55:18-25. [PMID: 29891432 DOI: 10.1016/j.parkreldis.2018.06.003] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
93 Johnson M, Salvatore M, Maiolo S, Bobrovskaya L. Tyrosine hydroxylase as a sentinel for central and peripheral tissue responses in Parkinson’s progression: Evidence from clinical studies and neurotoxin models. Progress in Neurobiology 2018;165-167:1-25. [DOI: 10.1016/j.pneurobio.2018.01.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
94 Knudsen K, Haase AM, Fedorova TD, Bekker AC, Østergaard K, Krogh K, Borghammer P. Gastrointestinal Transit Time in Parkinson's Disease Using a Magnetic Tracking System. J Parkinsons Dis 2017;7:471-9. [PMID: 28759975 DOI: 10.3233/JPD-171131] [Cited by in Crossref: 31] [Cited by in F6Publishing: 16] [Article Influence: 7.8] [Reference Citation Analysis]
95 Rao SSC, Tan G, Abdulla H, Yu S, Larion S, Leelasinjaroen P. Does colectomy predispose to small intestinal bacterial (SIBO) and fungal overgrowth (SIFO)? Clin Transl Gastroenterol. 2018;9:146. [PMID: 29691369 DOI: 10.1038/s41424-018-0011-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
96 Vizcarra JA, Wilson-Perez HE, Fasano A, Espay AJ. Small intestinal bacterial overgrowth in Parkinson's disease: Tribulations of a trial. Parkinsonism Relat Disord 2018;54:110-2. [PMID: 29636215 DOI: 10.1016/j.parkreldis.2018.04.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
97 Houser MC, Chang J, Factor SA, Molho ES, Zabetian CP, Hill-Burns EM, Payami H, Hertzberg VS, Tansey MG. Stool Immune Profiles Evince Gastrointestinal Inflammation in Parkinson's Disease. Mov Disord 2018;33:793-804. [PMID: 29572994 DOI: 10.1002/mds.27326] [Cited by in Crossref: 67] [Cited by in F6Publishing: 58] [Article Influence: 16.8] [Reference Citation Analysis]
98 Christine CW, Auinger P, Joslin A, Yelpaala Y, Green R; on behalf of the Parkinson Study Group-DATATOP Investigators. Vitamin B12 and Homocysteine Levels Predict Different Outcomes in Early Parkinson's Disease: B12 Status Predicts Early PD Outcomes. Mov Disord 2018;33:762-70. [DOI: 10.1002/mds.27301] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 6.8] [Reference Citation Analysis]
99 Johnson ME, Stringer A, Bobrovskaya L. Rotenone induces gastrointestinal pathology and microbiota alterations in a rat model of Parkinson’s disease. NeuroToxicology 2018;65:174-85. [DOI: 10.1016/j.neuro.2018.02.013] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 8.8] [Reference Citation Analysis]
100 Smith LM, Parr-brownlie LC. A neuroscience perspective of the gut theory of Parkinson's disease. Eur J Neurosci 2019;49:817-23. [DOI: 10.1111/ejn.13869] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
101 Ostojic SM. Inadequate Production of H2 by Gut Microbiota and Parkinson Disease. Trends Endocrinol Metab 2018;29:286-8. [PMID: 29478695 DOI: 10.1016/j.tem.2018.02.006] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
102 Zhang Z, Wang X, Han S, Liu C, Liu F. Effect of two seaweed polysaccharides on intestinal microbiota in mice evaluated by illumina PE250 sequencing. Int J Biol Macromol 2018;112:796-802. [PMID: 29427682 DOI: 10.1016/j.ijbiomac.2018.01.192] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
103 Nair AT, Ramachandran V, Joghee NM, Antony S, Ramalingam G. Gut Microbiota Dysfunction as Reliable Non-invasive Early Diagnostic Biomarkers in the Pathophysiology of Parkinson's Disease: A Critical Review. J Neurogastroenterol Motil 2018;24:30-42. [PMID: 29291606 DOI: 10.5056/jnm17105] [Cited by in Crossref: 79] [Cited by in F6Publishing: 68] [Article Influence: 19.8] [Reference Citation Analysis]
104 Ma K, Xiong N, Shen Y, Han C, Liu L, Zhang G, Wang L, Guo S, Guo X, Xia Y, Wan F, Huang J, Lin Z, Wang T. Weight Loss and Malnutrition in Patients with Parkinson's Disease: Current Knowledge and Future Prospects. Front Aging Neurosci 2018;10:1. [PMID: 29403371 DOI: 10.3389/fnagi.2018.00001] [Cited by in Crossref: 47] [Cited by in F6Publishing: 33] [Article Influence: 11.8] [Reference Citation Analysis]
105 Yang X, Qian Y, Xu S, Song Y, Xiao Q. Longitudinal Analysis of Fecal Microbiome and Pathologic Processes in a Rotenone Induced Mice Model of Parkinson's Disease. Front Aging Neurosci 2017;9:441. [PMID: 29358918 DOI: 10.3389/fnagi.2017.00441] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 12.5] [Reference Citation Analysis]
106 Pagano G, Yousaf T, Wilson H, Niccolini F, Polychronis S, Chaudhuri KR, Politis M. Constipation is not associated with dopamine transporter pathology in early drug-naïve patients with Parkinson's disease. Eur J Neurol 2018;25:307-12. [PMID: 29078029 DOI: 10.1111/ene.13503] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
107 Perez-pardo P, Kliest T, Dodiya HB, Broersen LM, Garssen J, Keshavarzian A, Kraneveld AD. The gut-brain axis in Parkinson's disease: Possibilities for food-based therapies. European Journal of Pharmacology 2017;817:86-95. [DOI: 10.1016/j.ejphar.2017.05.042] [Cited by in Crossref: 89] [Cited by in F6Publishing: 86] [Article Influence: 17.8] [Reference Citation Analysis]
108 Huang HK, Wang JH, Lei WY, Chen CL, Chang CY, Liou LS. Helicobacter pylori infection is associated with an increased risk of Parkinson's disease: A population-based retrospective cohort study. Parkinsonism Relat Disord. 2018;47:26-31. [PMID: 29174171 DOI: 10.1016/j.parkreldis.2017.11.331] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 8.2] [Reference Citation Analysis]
109 Perez-Pardo P, Hartog M, Garssen J, Kraneveld AD. Microbes Tickling Your Tummy: the Importance of the Gut-Brain Axis in Parkinson's Disease. Curr Behav Neurosci Rep 2017;4:361-8. [PMID: 29201595 DOI: 10.1007/s40473-017-0129-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
110 Erro R, Brigo F, Tamburin S, Zamboni M, Antonini A, Tinazzi M. Nutritional habits, risk, and progression of Parkinson disease. J Neurol 2018;265:12-23. [PMID: 29018983 DOI: 10.1007/s00415-017-8639-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 5.4] [Reference Citation Analysis]
111 Mischley LK, Lau RC, Bennett RD. Role of Diet and Nutritional Supplements in Parkinson's Disease Progression. Oxid Med Cell Longev 2017;2017:6405278. [PMID: 29081890 DOI: 10.1155/2017/6405278] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 9.0] [Reference Citation Analysis]
112 Wang L, Yu YM, Zhang YQ, Zhang J, Lu N, Liu N. Hydrogen breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in autism. Eur Child Adolesc Psychiatry 2018;27:233-40. [PMID: 28799094 DOI: 10.1007/s00787-017-1039-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
113 Schapira AHV, Chaudhuri KR, Jenner P. Non-motor features of Parkinson disease. Nat Rev Neurosci 2017;18:435-50. [PMID: 28592904 DOI: 10.1038/nrn.2017.62] [Cited by in Crossref: 429] [Cited by in F6Publishing: 407] [Article Influence: 85.8] [Reference Citation Analysis]
114 Su A, Gandhy R, Barlow C, Triadafilopoulos G. A practical review of gastrointestinal manifestations in Parkinson's disease. Parkinsonism & Related Disorders 2017;39:17-26. [DOI: 10.1016/j.parkreldis.2017.02.029] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 4.4] [Reference Citation Analysis]
115 Li W, Wu X, Hu X, Wang T, Liang S, Duan Y, Jin F, Qin B. Structural changes of gut microbiota in Parkinson’s disease and its correlation with clinical features. Sci China Life Sci 2017;60:1223-33. [DOI: 10.1007/s11427-016-9001-4] [Cited by in Crossref: 126] [Cited by in F6Publishing: 125] [Article Influence: 25.2] [Reference Citation Analysis]
116 Blaylock RL. Parkinson's disease: Microglial/macrophage-induced immunoexcitotoxicity as a central mechanism of neurodegeneration. Surg Neurol Int 2017;8:65. [PMID: 28540131 DOI: 10.4103/sni.sni_441_16] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 6.2] [Reference Citation Analysis]
117 Su A, Gandhy R, Barlow C, Triadafilopoulos G. Utility of the wireless motility capsule and lactulose breath testing in the evaluation of patients with Parkinson's disease who present with functional gastrointestinal symptoms. BMJ Open Gastroenterol 2017;4:e000132. [PMID: 28321329 DOI: 10.1136/bmjgast-2017-000132] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
118 Parashar A, Udayabanu M. Gut microbiota: Implications in Parkinson's disease. Parkinsonism Relat Disord 2017;38:1-7. [PMID: 28202372 DOI: 10.1016/j.parkreldis.2017.02.002] [Cited by in Crossref: 102] [Cited by in F6Publishing: 86] [Article Influence: 20.4] [Reference Citation Analysis]
119 Cheng X, Zhang L, Xie NC, Xu HL, Lian YJ. Association between small-intestinal bacterial overgrowth and deep vein thrombosis in patients with spinal cord injuries. J Thromb Haemost 2017;15:304-11. [PMID: 27930853 DOI: 10.1111/jth.13583] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
120 Lim S, Tan AH, Fox SH, Evans AH, Low SC. Integrating Patient Concerns into Parkinson’s Disease Management. Curr Neurol Neurosci Rep 2017;17. [DOI: 10.1007/s11910-017-0717-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
121 Houser MC, Tansey MG. The gut-brain axis: is intestinal inflammation a silent driver of Parkinson's disease pathogenesis? NPJ Parkinsons Dis 2017;3:3. [PMID: 28649603 DOI: 10.1038/s41531-016-0002-0] [Cited by in Crossref: 199] [Cited by in F6Publishing: 188] [Article Influence: 39.8] [Reference Citation Analysis]
122 van Laar T, Borgemeester R. The need for non-oral therapy in Parkinson's disease; a potential role for apomorphine. Parkinsonism Relat Disord 2016;33 Suppl 1:S22-7. [PMID: 27998652 DOI: 10.1016/j.parkreldis.2016.11.019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
123 Ray Chaudhuri K, Qamar MA, Rajah T, Loehrer P, Sauerbier A, Odin P, Jenner P. Non-oral dopaminergic therapies for Parkinson's disease: current treatments and the future. NPJ Parkinsons Dis 2016;2:16023. [PMID: 28725704 DOI: 10.1038/npjparkd.2016.23] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
124 Zhang Y, Liu G, Duan Y, Han X, Dong H, Geng J. Prevalence of Small Intestinal Bacterial Overgrowth in Multiple Sclerosis: a Case-Control Study from China. J Neuroimmunol 2016;301:83-7. [PMID: 27890460 DOI: 10.1016/j.jneuroim.2016.11.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
125 Niu XL, Liu L, Song ZX, Li Q, Wang ZH, Zhang JL, Li HH. Prevalence of small intestinal bacterial overgrowth in Chinese patients with Parkinson's disease. J Neural Transm (Vienna) 2016;123:1381-6. [PMID: 27589873 DOI: 10.1007/s00702-016-1612-8] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
126 Fialho A, Fialho A, Schenone A, Thota P, McCullough A, Shen B. Association between small intestinal bacterial overgrowth and deep vein thrombosis. Gastroenterol Rep (Oxf) 2016;4:299-303. [PMID: 27044499 DOI: 10.1093/gastro/gow004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
127 Deng L, Liu Y, Zhang D, Li Y, Xu L. Prevalence and treatment of small intestinal bacterial overgrowth in postoperative patients with colorectal cancer. Mol Clin Oncol 2016;4:883-7. [PMID: 27123301 DOI: 10.3892/mco.2016.807] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
128 Çamcı G, Oğuz S. Association between Parkinson's Disease and Helicobacter Pylori. J Clin Neurol 2016;12:147-50. [PMID: 26932258 DOI: 10.3988/jcn.2016.12.2.147] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 8.0] [Reference Citation Analysis]
129 Ali SA, Yin N, Rehman A, Justilien V. Parkinson Disease-Mediated Gastrointestinal Disorders and Rational for Combinatorial Therapies. Med Sci (Basel) 2016;4:E1. [PMID: 29083365 DOI: 10.3390/medsci4010001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
130 Hasegawa S, Goto S, Tsuji H, Okuno T, Asahara T, Nomoto K, Shibata A, Fujisawa Y, Minato T, Okamoto A, Ohno K, Hirayama M. Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson's Disease. PLoS One 2015;10:e0142164. [PMID: 26539989 DOI: 10.1371/journal.pone.0142164] [Cited by in Crossref: 209] [Cited by in F6Publishing: 189] [Article Influence: 29.9] [Reference Citation Analysis]
131 Klingelhoefer L, Reichmann H. Pathogenesis of Parkinson disease—the gut–brain axis and environmental factors. Nat Rev Neurol 2015;11:625-36. [DOI: 10.1038/nrneurol.2015.197] [Cited by in Crossref: 256] [Cited by in F6Publishing: 236] [Article Influence: 36.6] [Reference Citation Analysis]
132 Fang X. Potential role of gut microbiota and tissue barriers in Parkinson's disease and amyotrophic lateral sclerosis. Int J Neurosci. 2016;126:771-776. [PMID: 26381230 DOI: 10.3109/00207454.2015.1096271] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 5.7] [Reference Citation Analysis]
133 Mulak A, Bonaz B. Brain-gut-microbiota axis in Parkinson's disease. World J Gastroenterol 2015; 21(37): 10609-10620 [PMID: 26457021 DOI: 10.3748/wjg.v21.i37.10609] [Cited by in CrossRef: 316] [Cited by in F6Publishing: 274] [Article Influence: 45.1] [Reference Citation Analysis]
134 Barboza JL, Okun MS, Moshiree B. The treatment of gastroparesis, constipation and small intestinal bacterial overgrowth syndrome in patients with Parkinson's disease. Expert Opin Pharmacother 2015;16:2449-64. [PMID: 26374094 DOI: 10.1517/14656566.2015.1086747] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
135 Csoti I, Jost WH, Reichmann H. Parkinson's disease between internal medicine and neurology. J Neural Transm (Vienna) 2016;123:3-17. [PMID: 26298728 DOI: 10.1007/s00702-015-1443-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
136 Bu X, Wang X, Xiang Y, Shen L, Wang Q, Liu Y, Jiao S, Wang Y, Cao H, Yi X, Liu C, Deng B, Yao X, Xu Z, Zhou H, Wang Y. The association between infectious burden and Parkinson's disease: A case-control study. Parkinsonism & Related Disorders 2015;21:877-81. [DOI: 10.1016/j.parkreldis.2015.05.015] [Cited by in Crossref: 66] [Cited by in F6Publishing: 65] [Article Influence: 9.4] [Reference Citation Analysis]
137 Keshavarzian A, Green SJ, Engen PA, Voigt RM, Naqib A, Forsyth CB, Mutlu E, Shannon KM. Colonic bacterial composition in Parkinson's disease. Mov Disord 2015;30:1351-60. [PMID: 26179554 DOI: 10.1002/mds.26307] [Cited by in Crossref: 494] [Cited by in F6Publishing: 442] [Article Influence: 70.6] [Reference Citation Analysis]
138 Fasano A, Visanji NP, Liu LWC, Lang AE, Pfeiffer RF. Gastrointestinal dysfunction in Parkinson's disease. The Lancet Neurology 2015;14:625-39. [DOI: 10.1016/s1474-4422(15)00007-1] [Cited by in Crossref: 349] [Cited by in F6Publishing: 163] [Article Influence: 49.9] [Reference Citation Analysis]
139 Kim JS, Sung HY. Gastrointestinal Autonomic Dysfunction in Patients with Parkinson's Disease. J Mov Disord 2015;8:76-82. [PMID: 26090079 DOI: 10.14802/jmd.15008] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.9] [Reference Citation Analysis]
140 Park H, Lee JY, Shin CM, Kim J, Kim TJ, Kim JW. Characterization of gastrointestinal disorders in patients with parkinsonian syndromes. Parkinsonism & Related Disorders 2015;21:455-60. [DOI: 10.1016/j.parkreldis.2015.02.005] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
141 Cassani E, Barichella M, Cancello R, Cavanna F, Iorio L, Cereda E, Bolliri C, Zampella Maria P, Bianchi F, Cestaro B, Pezzoli G. Increased urinary indoxyl sulfate (indican): New insights into gut dysbiosis in Parkinson's disease. Parkinsonism & Related Disorders 2015;21:389-93. [DOI: 10.1016/j.parkreldis.2015.02.004] [Cited by in Crossref: 57] [Cited by in F6Publishing: 49] [Article Influence: 8.1] [Reference Citation Analysis]
142 Magallón S, Crespo-eguílaz N, Narbona J. Procedural Learning in Children With Developmental Coordination, Reading, and Attention Disorders. J Child Neurol 2015;30:1496-506. [DOI: 10.1177/0883073815572227] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
143 Tan AH, Mahadeva S, Marras C, Thalha AM, Kiew CK, Yeat CM, Ng SW, Ang SP, Chow SK, Loke MF, Vadivelu JS, Ibrahim N, Yong HS, Tan CT, Fox SH, Lang AE, Lim S. Helicobacter pylori infection is associated with worse severity of Parkinson's disease. Parkinsonism & Related Disorders 2015;21:221-5. [DOI: 10.1016/j.parkreldis.2014.12.009] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 9.1] [Reference Citation Analysis]